Literature DB >> 16917568

Defining and implementing a national policy for science, technology, and innovation in health: lessons from the Brazilian experience.

Reinaldo Guimarães1, Leonor Maria Pacheco Santos, Antonia Angulo-Tuesta, Suzanne Jacob Serruya.   

Abstract

The need for clearly-defined health research policies and priorities has been emphasized in the international scenario. In Brazil, this process began in 2003, when a group appointed by the National Health Council proposed 20 sub-agendas to account for the various health research specificities. The second step was to identify research priorities for each sub-agenda during national seminars involving 510 researchers and policymakers. The 2nd National Conference on Science, Technology, and Innovation in Health was held in July 2004. During the preparatory phase, 307 cities and 24 States organized local conferences, involving 15,000 participants. Some 360 health sector delegates were appointed during the local conferences, in addition to those from the education and science and technology sectors. During the Conference, the national policy was approved and 3 other sub-agendas were introduced and approved. The national policy and the priority agenda are currently guiding investments by the Ministry of Health for research and development, and to a certain extent those from the Ministry of Science and Technology as well. From 2003 to 2005, 24 calls for proposals were launched; as a result, 3,962 research projects were submitted and 1,300 financed.

Entities:  

Mesh:

Year:  2006        PMID: 16917568     DOI: 10.1590/s0102-311x2006000900002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  6 in total

1.  Fulfillment of the brazilian agenda of priorities in health research.

Authors:  Leonor Maria Pacheco Santos; Erly Catarina Moura; Rita de Cássia Barradas Barata; Suzanne Jacob Serruya; Marcia Luz da Motta; Flávia Tavares Silva Elias; Antonia Angulo-Tuesta; Ana Patricia de Paula; Gilvania de Melo; Reinaldo Guimarães; Carlos Augusto Grabois Gadelha
Journal:  Health Res Policy Syst       Date:  2011-08-31

2.  Corporate social responsibility to improve access to medicines: the case of Brazil.

Authors:  Halla Thorsteinsdóttir; Natasha Ovtcharenko; Jillian Clare Kohler
Journal:  Global Health       Date:  2017-02-21       Impact factor: 4.185

3.  How to strengthen a health research system: WHO's review, whose literature and who is providing leadership?

Authors:  Stephen R Hanney; Lucy Kanya; Subhash Pokhrel; Teresa H Jones; Annette Boaz
Journal:  Health Res Policy Syst       Date:  2020-06-23

4.  Direct from the COVID-19 crisis: research and innovation sparks in Brazil.

Authors:  Mário Fabrício Fleury Rosa; Everton Nunes da Silva; Christina Pacheco; Marcos Vinícius Pereira Diógenes; Christopher Millett; Carlos Augusto Grabois Gadelha; Leonor Maria Pacheco Santos
Journal:  Health Res Policy Syst       Date:  2021-01-21

5.  Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases.

Authors:  Carlos Medicis Morel; Suzanne Jacob Serruya; Gerson Oliveira Penna; Reinaldo Guimarães
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18

6.  Access to medicines in Latin America and the Caribbean (LAC): a scoping study.

Authors:  Isabel Cristina Martins Emmerick; Maria Auxiliadora Oliveira; Vera Lucia Luiza; Thiago Botelho Azeredo; Maryam Bigdeli
Journal:  BMJ Open       Date:  2013-05-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.